Search Results1-16 of  16

  • OHMORI Tohru ID: 9000001435964

    Department of Internal Medicine, Showa University School of Medicine (2005 from CiNii)

    Articles in CiNii:2

    • Characteristics of gefitinib-acquired resistant non-small cell lung cancer cell lines (2004)
    • Patients Preferences in Chemotherapy for Advanced Non-small-cell Lung Cancer (2005)
  • OHMORI Tohru ID: 9000019054053

    NIPPON DAISHOWA PAPERBOARD Co., Ltd. (2012 from CiNii)

    Articles in CiNii:1

    • No. I C/T Web Defect Inspection System, Sorting Control System Renewal (2012)
  • OHMORI Tohru ID: 9000240099783

    Institute of Molecular Oncology, Showa University School of Medicine (2012 from CiNii)

    Articles in CiNii:1

    • SECOND-LINE CHEMOTHERAPY IN PATIENTS WITH RELAPSED ADVANCED NON-SMALL LUNG CANCER (2012)
  • OHMORI Tohru ID: 9000255736427

    <I>Institute of Molecular Oncology, Showa University School of Medicine</I> (2007 from CiNii)

    Articles in CiNii:1

    • Comparison of Biweekly and Triweekly Therapy with Docetaxel and Irinotecan for Refractory or Relapsed Advanced Non-small-cell Lung cancer (2007)
  • OHMORI Tohru ID: 9000255736498

    <I>First Department of Internal Medicine, Showa University School of Medicine</I>|<I>Institute of Molecular Oncology, Showa University School of Medicine</I> (2007 from CiNii)

    Articles in CiNii:1

    • Gefitinib Cytotoxicity in Non-small Cell Lung Cancer Cells is Enhanced by Low Dose Cisplatin Due to Ligand-independent EGFR Autophosphorylation (2007)
  • OHMORI Tohru ID: 9000256139036

    <I>First Department of Internal Medicine, Showa University School of Medicine</I>|<I>Institute of Molecular Oncology, Showa University School of Medicine</I> (2004 from CiNii)

    Articles in CiNii:1

    • Enhancement of Epidermal Growth Factor Receptor-degradation Pathway in Acquired Gefitinib-resistant Human Non-small Cell Lung Cancer Cell Lines (2004)
  • OHMORI Tohru ID: 9000256139798

    <I>The First Department of Internal Medicine, Showa University School of Medicine</I> (1992 from CiNii)

    Articles in CiNii:1

    • Reevaluation of Ifosfamide in Patients with Non-small Cell Lung Cancer (1992)
  • OHMORI Tohru ID: 9000361697149

    Institute of Molecular Oncology, Showa University (2017 from CiNii)

    Articles in CiNii:1

    • Comparing the Adverse Event Profiles of Nivolumab and Docetaxel in Previously-treated or Refractory Advanced Non-small Cell Lung Cancer: A Meta-analysis of Two Phase 3 Trials (2017)
  • OHMORI Tohru ID: 9000375885911

    Institute of Molecular Oncology, Showa University (2017 from CiNii)

    Articles in CiNii:1

    • A Comparison of Adverse Effect Profiles of Two Anti-IL-5 Therapies in Adults with Uncontrolled Asthma:―A Network Meta-analysis of Phase 3 Trials― (2017)
  • OHMORI Tohru ID: 9000388515150

    Institute of Molecular Oncology, Showa University (2017 from CiNii)

    Articles in CiNii:1

    • EGFR-TKI Versus Chemotherapy for Previously Untreated Advanced Non-Small Cell Lung Cancer in Asians: A Meta-Analysis (2017)
  • OHMORI Tohru ID: 9000396128047

    Institute of Molecular Oncology, Showa University (2018 from CiNii)

    Articles in CiNii:1

    • Comparative Efficacy and Safety of Anti-Interleukin-5 Therapies and Placebo in Patients with Uncontrolled Eosinophilic Asthma::A Systematic Review and Meta-analysis of Phase 3 Trials (2018)
  • OHMORI Tohru ID: 9000396128059

    Institute of Molecular Oncology, Showa University (2018 from CiNii)

    Articles in CiNii:1

    • A Long-acting Muscarinic Antagonist (LAMA) Added to an Inhaled Corticosteroid and Long-acting Beta-2 Agonist Versus LAMA Alone in Moderate-to-severe Chronic Obstructive Pulmonary Disease::A Systematic Review and Meta-analysis of Randomized Trials (2018)
  • OHMORI Tohru ID: 9000398131855

    Institute of Molecular Oncology, Showa University (2018 from CiNii)

    Articles in CiNii:1

    • Alectinib Versus Crizotinib for Previously Untreated Alk-positive Advanced Non-small Cell Lung Cancer : A Meta-Analysis (2018)
  • OHMORI Tohru ID: 9000398131947

    Institute of Molecular Oncology, Showa University (2018 from CiNii)

    Articles in CiNii:1

    • Efficacy and Safety of Long-acting Beta-2 Agonist and Long-acting Muscarinic Antagonist Combinations in Patients with Chronic Obstructive Pulmonary Disease: Meta-analysis of Phase 3 Randomized Trials (2018)
  • Ohmori Tohru ID: 9000253626230

    The First Department of Internal Medicine, Showa University School of Medicine (1995 from CiNii)

    Articles in CiNii:1

    • Three Patients with Spontaneous Pneumomediastinum, Including One in Whom Pneumomediastinum Recurred. (1995)
  • Ohmori Tohru ID: 9000402785872

    Institute of Molecular Biology, Showa University|Department of Respiratory Tract and Allergy Medicine, Showa University School of Medicine (2008 from CiNii)

    Articles in CiNii:1

    • Differences of phosphorylated substrates between wild type and a mutant EGFR by TGFα stimulation (2008)
Page Top